Know Cancer

or
forgot password
  • cancer clinical trials in dallas, TX

  • Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas

    Trial Locations
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Baylor University Medical Center - Dallas
    Lung Cancer
    Patients Treated for SCID (1968-2010)
    University of Texas Southwestern Medical Center/Children's of Dallas
    Dallas, Texas 75390-9263
    SCID, ADA-SCID, XSCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Baylor University Medical Center

    Trial Locations
    Baylor University Medical Center
    University of Texas Southwestern Medical Center
    Children's Medical Center Dallas
    Medical City Dallas
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    National Marrow Donor Program Long-Term Donor Follow-Up
    Baylor Research Institute
    Dallas, Texas 75246
    Hematologic Neoplasms
    A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
    Texas Oncology-Baylor Charles A. Sammons Cancer Center
    Dallas, Texas 75246
    Non Small Cell Lung Cancer
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    University of Texas Southwestern Medical Center
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
    University of Texas Southwestern Medical Center UT southwest
    Dallas, Texas 75390-8527
    Cushing's Disease
    A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
    US Oncology Central Monitoring
    Dallas, Texas 75246
    Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment, VEGF
    A Safety and Efficacy Study of Uvadex and Extracorporeal Photopheresis (ECP) in Chronic Graft Versus Host Disease
    Parkland Memorial Hospital

    Trial Locations
    Parkland Memorial Hospital
    Medical City Dallas Hospital,Transplant center
    Chronic Graft Versus Host Disease
    HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer
    Ut Southwestern Medical Center
    Dallas, Texas 75390
    Hepatocellular Carcinoma
    Safety Study of Adenovirus Vector Engineered to Express hIL-12 (Human Interleukin 12) in Combination With Activator Ligand to Treat Melanoma
    Mary Crowley Cancer Research Center
    Dallas, Texas 75246
    Unresectable Stage III or IV Melanoma
    Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Oral Mucositis
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    University of Texas Southwestern Medical Center
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Cervical Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexuality and Reproductive Issues
    Hippocampal-Avoiding Whole Brain Irradiation With Simultaneous Integrated Boost for Treatment of Brain Metastases
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Brain Metastasis.
    Phase 1-2 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
    Mary Crowley Cancer Research Center
    Dallas, Texas 75246
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
    Sammons Cancer Center Sammons Cancer Center SC-2
    Dallas, Texas 78246
    Advanced Solid Tumors, Excluding Breast Cancer
    A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
    Texas Oncology - Baylor Charles A Sammons Cancer Center

    Trial Locations
    Texas Oncology - Baylor Charles A Sammons Cancer Center
    Texas Oncology - Medical City
    Texas Oncology - Dallas
    ER Positive, Her2 Negative Breast Cancer Patients, Triple Negative Breast Cancer Patients
    Evaluation of CureXcell™ in Treating Lower Extremity Chronic Ulcers in Adults With Diabetes
    South Hampton Community Hospital
    Dallas, Texas 75224
    Lower Extremity Chronic Ulcers in Diabetics
    Objective Assessment of Technical Skills in Cardiothoracic Surgery
    The University of Texas Southwestern Medical Center in Dallas
    Dallas, Texas 75390
    Other Surgical Procedures
    Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
    Baylor Univesity Medical Center
    Dallas, Texas 75246
    Melanoma, Malignant Melanoma
    Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer
    Texas Oncology-Methodist Charlton Cancer Center

    Trial Locations
    Texas Oncology-Methodist Charlton Cancer Center
    Texas Oncology-Dallas Presbyterian Hospital
    Texas Oncology-Baylor Charles A. Sammons Cancer Center
    Texas Oncology-Medical City Dallas
    Estrogen Receptor Positive Tumor, Breast Cancer
    Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
    Mary Crowley Cancer Center
    Dallas, Texas 75246
    Solid Tumour, Adenocarcinoma of the Colorectal, Adenocarcinoma of the Pancreas
    Phase II FANG in Advanced Melanoma
    Mary Crowley Cancer Research Centers
    Dallas, Texas 75201
    Advanced Melanoma
    Phase 1 Pharmacokinetics Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
    Mary Crowley Cancer Research Centers
    Dallas, Texas 75201
    Nonhematologic Malignancies, Lymphoma
    A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
    Texas Oncology, P.A.
    Dallas, Texas 75246
    Urologic Neoplasms, Metastatic Bladder Cancer, Urinary Tract Neoplasms
    Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
    Baylor Research Institute
    Dallas, Texas 75246
    Multiple Myeloma
    A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors
    University of Texas Southwestern Medical Center

    Trial Locations
    University of Texas Southwestern Medical Center
    Texas Oncology - Baylor, Charles A. Sammons Center
    Multiple Myeloma, Solid Tumors, Non-Small Cell Lung Cancer
    Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
    UT Southwestern
    Dallas, Texas 75390
    Leukemia, Pediatric
    Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
    Texas Oncology - Medical City Dallas

    Trial Locations
    Texas Oncology - Medical City Dallas
    Texas Oncology - Dallas Presbyterian
    Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, Solid Tumors